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http:WHAT THIS PAPER ADDS
We report contemporary long-term renal outcomes following open type IV thoracoabdominal aneurysm (TAAA)
repair within a centralised, high-volume UK centre. This study describes the trends in renal function following
open TAAA surgery, which, following an early and signiﬁcant postoperative creatinine rise, returns to baseline
level on discharge and at follow up (>1 year postoperatively). Renal function improved in a similar proportion to
those in whom renal function declined, and remained stable in approximately half of patients. In the era of
endovascular repair, with its incumbent concerns regarding a gradual decline in renal function, we report du-
rable outcomes following open surgery.Objective: To evaluate long-term renal outcomes after open type IV thoracoabdominal aneurysm (TAAA) repair.
Design: Retrospective analysis of a prospectively collected database of consecutive operated non-ruptured type
IV TAAAs (2007e2011).
Methods: Renal function was analysed by serum creatinine concentration, estimated glomerular ﬁltration rate
(eGFR) and Kidney Disease Outcomes Quality Initiative (KDOQI) stage. The primary outcome was the change in
creatinine concentration from before surgery to deﬁned time points after surgery: peak postoperative; discharge;
at follow-up (>1 year postoperatively). Secondary outcomes were change in eGFR, change in KDOQI stage,
dialysis requirement, and 30-day mortality.
Results: Between 2007 and 2011, 53 open type IV TAAA repairs were performed. Median creatinine levels
signiﬁcantly increased in the immediate postoperative period, but returned to baseline by discharge. Thirteen
patients (28.2%) had an improvement in follow-up eGFR of at least 20% compared with pre-operative eGFR or
improved by one KDOQI stage. Twelve patients (26.1%) had a decline in eGFR of at least 20% or one KDOQI stage
at follow-up. Three patients (7.5%) required temporary dialysis and one patient (1.9%) required permanent
dialysis. The 30-day mortality was 1.9%.
Conclusions: This study demonstrates acceptable renal outcomes following open type IV TAAA repair. Open type
IV repair remains the standard against which newer techniques should be compared.
 2013 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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The Crawford classiﬁcation of thoracoabdominal aneurysm
(TAAA) deﬁnes type IV as aneurysmal change extending
distally from the diaphragm and involving the origins of the
coeliac, mesenteric, and renal arteries.1 We have previously
presented the outcome data for type IV thoracoabdominal
repair over a 10-year period with a 1-year mortality of 6%.2
Open type IV TAAA repair involves supra-coeliac aortic
cross-clamping, and the consequent renal ischaemia canresponding author. R.T.A. Chalmers, Vascular Surgical Service, Royal
ry of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK.
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//dx.doi.org/10.1016/j.ejvs.2013.08.015often lead to postoperative renal dysfunction.3 However,
increasingly advanced peri-operative anaesthetic, medical,
and surgical management may help to minimise the impact
of extensive surgery and supra-renal cross clamping.
The endovascular repair of TAAAs is becoming increas-
ingly prevalent; however, it requires the administration of
nephrotoxic contrast during the procedure and instrumen-
tation of the visceral vessel ostia with an associated risk of
microembolisation.4 Furthermore, endovascular stent grafts
require regular follow-up imaging, and are associated with
late complications such as endoleak and renal artery branch
stenosis or occlusion.4,5
The aim of this study was to assess contemporary renal
outcomes following open type IV repair in order to provide
a benchmark against which newer techniques can be
compared.
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Consecutive patients undergoing type IV TAAA repair were
entered into a prospectively collected database between 1
January 2007 and 31 December 2011 at the Royal Inﬁrmary
of Edinburgh, UK, which is the national centre for the
treatment of thoracoabdominal aneurysms in Scotland.
Patients were included if they had undergone non-ruptured
(including urgent/symptomatic) open Crawford type IV
TAAA repair. Patients were excluded if they had undergone
any operation other than open Crawford type IV repair, so
that hybrid or endovascular repairs were excluded.
Patient demographics, pre-operative co-morbidities,
intra-operative parameters, and peri-operative complica-
tions were recorded.
Patient selection
Open type IV TAAA repair is offered to patients with
>5.5 cm diameter, rapidly expanding, or symptomatic an-
eurysms. Patients are pre-assessed by a consultant surgeon
and anaesthetist, with pre-operative tests usually including
electrocardiogram, chest radiograph, and stress echocar-
diogram. Patients included towards the end of the study
period were also assessed using cardiopulmonary exercise
testing, and computed tomography (CT) coronary angiog-
raphy. There is no renal function threshold below which
surgery is not offered.
Operative methodology
All operations were performed in a similar manner with one
of the two senior authors (P.J.B or R.T.A.C) as primary
operator. All patients had epidural and general anaesthesia
with one of the anaesthetists (A.F.N or C.M) as the primary
anaesthetist. A cerebrospinal ﬂuid (CSF) drain for spinal
cord protection was sited only in patients who had under-
gone previous thoracic aortic aneurysm repair. All opera-
tions were undertaken through an abdominal approach.
Medial visceral rotation was used for aortic exposure.
Before aortic clamping the patient was cooled to 32e33 C
by a combination of lowering the operating room temper-
ature, passing cold water through under-body blankets, and
blowing ambient temperature air over the upper body.
Intravenous mannitol was administered before aortic
clamping.6 Following systemic heparinisation (5000 Units or
70 Units/kg), a supra-coeliac aortic cross clamp was applied
and a bevelled Crawford type IV repair was performed
incorporating the renal and visceral ostia into the repair. A
Dacron graft (Maquet, Rastatt, Germany) was used for
repair. Renal and visceral ischaemic time was kept to a
minimum. No local cooling of the kidneys or infusion of
drugs or ﬂuids into the renal arteries was employed.
Depending upon the distance between the visceral ostia,
some patients required a renal artery jump-graft (the longer
of the ischaemic times presented).
Red cell salvage, and frequent point-of-care testing of
arterial blood gases, electrolytes, glucose, lactate, and
coagulation (ROTEM thromboelastometry; TEM Interna-
tional, Munich, Germany) were undertaken during surgery.After reperfusion of the kidneys and other abdominal
viscera, rewarming of the patient was commenced. In most
cases the tracheal tube was removed in the operating
theatre when the patient was normothermic (36 C). The
patient was subsequently transferred to the High De-
pendency Unit (HDU) or Intensive Care Unit (ICU) for
postoperative care.
Serum creatinine was measured the day before surgery,
after surgery in the recovery room, or on admission to the
HDU and ICU at least once daily while the patient was in
HDU or ICU, and at less frequent intervals once the patient
was transferred back to the vascular surgery ward. Three
subgroups were identiﬁed for analysis: (1) standard repair
(no jump graft); (2) those requiring a renal jump graft; and
(3) those with a pre-operative estimated glomerular ﬁltra-
tion rate of <60 mL/min.
Outcome measures of renal function
Within the literature there are multiple methods of
measuring renal function.7 Many studies primarily use
serum creatinine changes,8 whereas others support the use
of glomerular ﬁltration rate (GFR) and Kidney Disease
Outcomes Quality Initiative (KDOQI) stage9 as a more sen-
sitive determinant of early renal dysfunction.7 To present
our data in a transparent fashion and to allow comparison
with published data from other centres, we have analysed
the data using all three methods.
1. Creatinine concentration
Creatinine (mmol/L) was recorded from patient notes,
and electronic and general practice (GP) records pre-
operatively, peak postoperatively, at discharge, and at
follow up (>1 year postoperatively).
The primary outcome was a change in baseline creatinine
levels between before surgery and the postoperative time
points mentioned above. In order to compare our results
with other published data, we analysed data using the
following deﬁnitions of renal dysfunction: creatinine
>1.5 mg/dL (¼133 mmol/L) and increase in baseline
creatinine of at least 50%.10
2. Estimated GFR and KDOQI stage
The GFR has been described by some authors as a more
sensitive measure of chronic renal impairment then serum
creatinine concentration, and pre-operative GFR has been
shown to correlate with mortality after TAAA repair.7,11,12
Estimated GFR (eGFR; mL/min) was calculated according
to the Cockcroft-Gault formula ([140-age]  weight
(kg)  constant/creatinine (mmol/L) [constant ¼ 1.23 men
and 1.04 women]).13 Patients were then stratiﬁed according
to the KDOQI stages of chronic kidney disease using this
calculated eGFR (“Normal” or “Stage 1”: eGFR 90 mL/min;
“Stage 2”: eGFR 60e89 mL/min; “Stage 3”: eGFR 30e
59 mL/min; “Stage 4”: eGFR 15e29 mL/min).9 We deﬁned
deterioration in renal function as a decline from pre-
operative to follow up eGFR by 20% or moving down a
Table 1. Patient demographics and peri-operative variables in operated and non-operated type IV thoracoabdominal aneurysms (TAAAs).
All type IV repairs and non-operatively managed TAAAs are compared using ManneWhitneya or Fisher’s exact testb.
Operated open type IV TAAA Non-operatively
managed
p
(All type IV repairs
versus non-operative
management)
All type
IV repairs
Renal
jump
graft
Pre-operative
eGFR
<60 mL/min
Number 53 7 21 21 e
Age (y; median) 70 66 70 74 .003a
Sex (M/F) 41/12 6/1 11/10 17/4 1.0b
Mean weight (kg) 76.0 75.4 70.6 e e
Median aneurysm
diameter (cm)
6.8 7.7 7.0 6.2 .03a
Ischaemic heart disease 19 2 8 13 .06b
Positive stress
echocardiogram
7 1 4 9 .01b
Median preoperative
creatinine (mmol/l)
99 140 135 105 .3a
Median estimated
glomerular ﬁltration rate
(mL/min)
66.3 50.8 44 e e
Pre-operative renal artery
stenosis on CT
6 3 4 e e
Previous aortic surgery 7 0 1 1 .4b
Median renal ischaemic
time in mins (range)
46 (30e104) 75 (60e104) 46 (32e104) e e
30-day mortality 1 0 1 e e
640 N.T. Ventham et al.stage in KDOQI scale in line with other reports.7 Freedom
from deterioration in renal function was calculated using
the KaplaneMeier method allowing for variable follow-up
lengths. A comparison between the subgroups (eGFR
60 mL/min, eGFR <60 mL/min, and renal jump grafts)
was performed using the logrank test.
3. Other variables
The temporary or permanent dialysis requirement and
30-day mortality were also recorded.
Statistical analysis
Variables were entered into a Microsoft Excel version 14.2.3
worksheet and analysis was performed using R environment
for statistical computing (reference index version 3.0.1; R
Foundation for Statistical Computing, Vienna, Austria).
Fisher’s exact test was used to compare categorical data
due to small counts. Where given creatinine was deemed
unlikely to be normally distributed, non-parametric tests
were used. The ManneWhitney U test was used to
compare continuous variables. To compare creatinine re-
sults for the same individuals at different time periods a
Wilcoxon rank signed test was used. The KaplaneMeier
method was used to analyse freedom from deterioration
renal function. A logrank test was performed to compare
survival curves between subgroups. A p-value <.05 was
considered signiﬁcant.
RESULTS
Between 2007 and 2011, 73 patients were referred to the
Royal Inﬁrmary of Edinburgh for consideration for type IVTAAA repair. Fifty-three patients underwent type IV TAAA
repair by one of the two senior authors (P.J.B/R.T.A.C) as
primary operator. Twenty patients were managed non-
operatively for the following reasons: cardiac disease
(nine), cardiac and renal disease (three), malignant disease
(two), respiratory disease (three), renal and respiratory
disease (one), and patient choice (two). Patient de-
mographics and operative parameters, and comparison
between patients managed operatively and non-
operatively, are presented in Table 1. Seven patients had
undergone previous aortoiliac surgery (four infra-renal open
abdominal aortic aneurysm [AAA] repair, one thoracic
endovascular aortic aneurysm repair [TEVAR], one endo-
vascular AAA repair, one common iliac artery endarterec-
tomy). One patient who had previously undergone TEVAR
had a CSF drain inserted pre-operatively. One patient within
the cohort died within 30 days of operation as a result of a
cerebral infarction and was excluded from further analysis.
Four patients required dialysis postoperatively (7.5%).
Three of these patients (all renal jump graft patients)
required temporary dialysis postoperatively, and success-
fully recovered from dialysis dependence. One patient
(1.9%) went on to require lifelong dialysis and was excluded
from further discharge and follow-up creatinine analyses.
This patient was at high pre-operative risk of developing
renal failure (pre-operative CT showed bilateral renal atro-
phy and pre-operative creatinine >200 mmol/l). Full data on
all patients were available for pre-operative and peak
creatinine. Discharge creatinine was available for all pa-
tients, apart from the patient who died. Follow-up creati-
nine (mean time from surgery ¼ 2.5 years, range 52e265
weeks) was obtained from GP records and was missing from
Table 2. Median difference in pre-operative creatinine and at various peri-operative stages in (1) all type IV repairs; (2) renal jump graft
repairs; and (3) patients with a pre-operative estimated glomerular ﬁltration rate (eGFR) <60 mL/min.
Median creatinine
(mmol/L)
IQR Difference in medians from
pre-operation [IQR]
p
(1) All type IV repairs (n ¼ 46)
Pre-operative 98 79e116 e e
Peak postoperative 150 106e233 45 (12e122) <.001
Discharge 92 68e118 10 (23 to 10) .2
Follow up 92 80e118 8 (17 to 10) .1
(2) Renal jump graft (n ¼ 7)
Pre-operative 140 116e144 e e
Peak postoperative 273 210e440 133 (100e284) .02
Discharge 166 126e172 13 (2 to 29) .2
Follow up 113 90e144 1 (22 to þ1) .4
(3) eGFR <60 mL/min (n ¼ 20)
Pre-operative 135 105e145 e e
Peak postoperative 176 140e256 47 (1e133) .002
Discharge 114 90e142 23 (37 to 9) .2
Follow up 117 100e141 10 (25 to 1) .1
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follow-up period, one patient failed to return for follow up,
one patient moved GP practice).
Creatinine concentration
Table 2 shows the median creatinine levels (mmol/l) at the
various stages postoperatively. Median creatinine was
signiﬁcantly elevated immediately postoperatively (differ-
ence in medians þ45, interquartile range 12e122, p
.001); however, the median creatinine returned towards
the baseline level at discharge and at follow up. The median
creatinine at follow up in all subgroups was lower than the
pre-operative creatinine; however, this result failed to reach
statistical signiﬁcance. Several studies10 deﬁne renal failure
as creatinine >1.5 mg/dl (¼133 mmol/l); when using this
arbitrary cut-off, 10 (21.7%) patients had a pre-operative
creatinine >133 mmol/l compared with six (13.3%) at
follow up (p ¼ .4). Some studies deﬁne renal failure as in-
crease in baseline creatinine by 50%;10 by this deﬁnition no
patients had renal failure on follow up.
eGFR and KDOQI stage
Table 3 summarises changes in eGFR and KDOQI between
before surgery and follow up after surgery. Eleven patientsTable 3. Changes in estimated glomerular ﬁltration rate (eGFR) and
Kidney Disease Outcome Quality Initiative (KDOQI) stages between
pre-operative levels and follow up (>1 year postoperatively) after
open type IV thoracoabdominal aneurysm (TAAA) repair.
Open type IV TAAA
repairs n ¼ 46 (%)
eGFR decline >20% 8 (17.4)
KDOQI stage decline 6 (13.0)
eGFR decline >20% and/or
KDOQI stage decline
11 (23.9)
eGFR improvement >20% 13 (28.2)
KDOQI stage improvement 4 (8.7)
eGFR improvement >20%
and/or KDOQI stage improvement
13 (28.2)had a decline in eGFR by 20% or one KDOQI stage at follow-
up. The eGFR was <60 mL/min in 19 patients pre-
operatively compared with 19 patients at follow up,
which was not signiﬁcant (p ¼ 1.0). Fig. 1 demonstrates the
KaplaneMeier deterioration in renal function-free survival
of TAAA patients with pre-operative eGFR >60, eGFR <60,
and renal jump graft patients. There were no signiﬁcant
differences in deterioration in renal function survival be-
tween subgroups (p ¼ .5).DISCUSSION
Our results demonstrate that, after open type IV TAAA
repair, renal function is preserved or improved in the ma-
jority, and declines in just under a quarter of patients. This
echoes the ﬁndings of a contemporary series analysing
long-term renal outcomes in open type IV repair.14 Nathan
et al.14 reported that the renal function of 25.3% of patients
declined by one KDOQI stage and that the renal function of
19% of patients improved by one KDOQI stage. This is
similar to the results reported in our study (Table 3). It can
be difﬁcult to directly compare renal outcomes betweenFigure 1. KaplaneMeier freedom from deterioration in renal
function over time (renal function deterioration deﬁned as decline
in pre-operative estimated glomerular ﬁltration rate [eGFR] by
20% or moving down a stage in the Kidney Disease Outcomes
Quality Initiative scale).
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dysfunction, as well as a lack of published medium-to-long-
term renal data following type IV repair.3 When considering
infra-renal AAA, Mills et al.7 reported a long-term 20%
decline in eGFR in 21% of patients undergoing open and
endovascular repair, which is, again, comparable with our
result of a 20% decline in eGFR in 17.4% of patients 1 year
after open type IV repair. The outcomes of dialysis
requirement and 30-day mortality appear to be the most
universally reported and easily compared variables. Our
reported rates of dialysis and 30-day mortality rate compare
favourably with other type IV open case series, although we
did not include ruptures in our analysis (Table 4).14e20 One
patient (1.9%) in a 5-year period required permanent dial-
ysis and was known pre-operatively to be at high risk of
developing permanent renal failure (pre-operative bilateral
renal atrophy pre-operative creatinine >200 mmol/L). Three
patients (5.8%), all of whom had undergone renal jump
graft, required temporary dialysis. Patients requiring renal
jump graft repair are recognised as having a higher risk for
acute renal failure and dialysis postoperatively.21
The satisfactory renal outcomes presented follow open
type IV TAAA with no speciﬁc renal perfusion techniques.
The operative technique for type IV at our centre focuses on
minimising aortic clamping times and induced systemic
hypothermia to reduce metabolic demand. In an effort to
prevent end-organ ischaemic injury, various renal protective
techniques have been described. Cold crystalloid renal
perfusion was described more than 30 years ago, and in
randomised trials demonstrated reduced renal dysfunction
compared with isothermic, but not cold, blood perfu-
sion.22,23 The authors of these studies postulate that cold
renal perfusion protects against renal dysfunction, and the
substrate (blood, crystalloid, mannitol) used is less impor-
tant.24 Additional measures, such as left heart bypass,
balloon perfusion catheters, and shunts, have been used for
selective visceral perfusion.25,26 While these measures are
undoubtedly useful for extent types I and II, the role in type
IV repair is less clear. Similarly, at our centre, endarterec-
tomy or stenting is not routinely performed in the case of
renal artery stenosis.Table 4. Comparison of clinical outcomes of type IV thoracoabdomina
Author (year) Number of
patients
Mean
age (y)
Short-term
30-d renal dysfunctio
Doubling of creatinine
creatinine >3.0 g/dL
This study 53 68.6 13 (24.5)
Nathan et al. (2011)14 108 72.9 e
Patel et al. (2011)18 179 73 8 (4.5)
Coselli (2007)24 427 66.1a e
Bicknell (2003)15 130 68 e
Cinà et al. (2002)16 42 69a 17 (40.4)
LeMaire et al. (2001)19 207 e e
Schwartz et al. (1996)20 58 70 16 (28)
Note. KDOQI ¼ kidney disease outcome quality initiative.
a Mean age for all types of aneurysm; mean age of type IV not detailThis study demonstrates the common clinical scenario of
an acute creatinine rise immediately after surgery followed
by a gradual improvement towards baseline by discharge.3
An important ﬁnding from this study is that renal function
typically remains stable following discharge. Indeed, there
was a trend towards lower median creatinine concentration
at follow-up compared with pre-operative levels in all
subgroups; however, this was not statistically signiﬁcant.
Possible reasons for this may not be exclusively surgical, and
may involve the addressing of cardiovascular risk factors, for
example blood pressure control. When considering infra-
renal AAA, there have been reports of a late decline in
renal function in those undergoing endovascular stent
grafting, perhaps as a result of repeated doses of nephro-
toxic contrast administered for surveillance CT scans.7,8
Endovascular repair of TAAAs may be associated with late
renal artery branch occlusion4,5 occasionally causing dete-
rioration in renal function or dialysis requirement.4,27
Endovascular repair can also be associated with a high re-
intervention rate (10%).5,27 A study of fenestrated endor-
epair of supra-renal (n ¼ 13), juxtarenal (n ¼ 63), and four
type IV TAAAs has shown good results with a worsening in
renal function in 11%, improvement in 19%, a temporary
dialysis rate of 3%, and long-term dialysis rate of 1%.5 A
study of 119 juxtrarenal aneurysms repaired by fenestrated
endovascular grafts reported a worsening of renal function
in 25%.4 The authors postulated that the reason for renal
impairment in this context could be nephrotoxic contrast or
micro-embolisation from manipulation of the device within
the aorta. A total of 22 renal stenoses and occlusions
occurred in the course of follow-up in that study (12 renal
artery stenoses and 10 renal artery occlusions). Five pa-
tients required dialysis (two permanently); this included
four patients with renal artery occlusions. The largest UK
series of total endovascular repairs of type IeIV TAAAs re-
ported a median 3.4% deterioration in eGFR at discharge, a
temporary dialysis rate of 6.5%, and a permanent dialysis
rate of 3.2%.28 Although renal outcomes published
following open type IV surgery may suggest superiority over
endovascular repair, the aforementioned endovascular
studies consist of an older cohort of patients with more co-l aneurysm repair with other published data.
n
Long-term renal
dysfunction
Dialysis Operative
mortality or
30-d mortalityor
(%)
Decrease in
KDOQI stage (%)
Temporary
dialysis (%)
Permanent
dialysis (%)
6 (13) 3 (5.7) 1 (1.9) 1 (1.9)
25 (25.3) e 6 (6.1) 6 (5.6)
e 5 (2.8) e 5 (2.8)
e e 23 (5.4) 13 (3)
e 20 (15) e 22 (19.9)
e 4 (9.5) 2 (1.8) 2 (4.8)
e e 11 (5.4) 8 (3.9)
e 5 (8.8) 1 (1.9) 2 (5.3)
ed.
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for TAAAs is slightly less clear. A recent meta-analysis for
hybrid repairs (types IeV) demonstrated a dialysis
requirement of 8.8%.29Limitations
The main limitation of this study is the retrospective design.
Results are available only from operated patients, poten-
tially introducing selection bias of those patients ﬁt enough
to undergo a major operation. Renal function was assessed
using serum creatinine derived from blood tests taken
postoperatively, at clinic visits, and GP practice records. As a
consequence, the interval between operation and creati-
nine measurement was variable between patients. Mea-
sures of renal function, such as inulin clearance, may be
more accurate in the prospective setting. Another limitation
of the retrospective study design was the inability to obtain
>1 year renal function results in six patients, mainly as a
result of mortality within the follow-up period (four
patients).
We feel that a centralised, high-volume centre with
specialised anaesthetic and surgical techniques and peri-
operative management, as well as rigorous patient assess-
ment and selection, is key in obtaining these positive renal
outcomes. Given the mixed long-term renal outcomes
following hybrid and totally endovascular repair of type IV
TAAAs, we advocate that open repair remains the standard
to which these newer methods are compared.
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